What You Should Know:
– The partnership will allow AccurKardia to integrate its FDA-cleared ECG interpretation software platform, AccurECG, into Lucem Health’s Reveal family of solutions, which identify patients who may be at higher risk of severe or chronic diseases.
Automated ECG Interpretation Cloud-Based Software Solution
AccurECG is a cloud-based, device-agnostic, fully automated ECG interpretation software platform that can detect up to 13 arrhythmias. The partnership will help clinicians review ECGs more efficiently and enable prompt treatment of patients with cardiovascular diseases. Lucem Health’s Reveal solutions provide a unique way to identify patient health risks that may not be immediately apparent.
“Our software helps clinicians review ECGs more efficiently and enables prompt treatment of patients, with key cardiovascular insights delivered in minutes. This partnership with Lucem Health allows us to bring the power of our technology to Lucem Health’s clinical AI solution,” said Juan C. Jiménez, CEO of AccurKardia. “This is an important step in our mission to improve patients’ outcomes and save lives at scale.”
The two companies plan to announce their first product incorporating AccurKardia’s FDA-cleared technology later this year.